PATHOGENESIS OF HUMAN AND MURINE HYPERCALCIURIA

$107,753P01FY2000DKNIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 39340639 Paper 39281877 Paper 38251931 Paper 37823200 Paper 37530089 Paper 37468583 Paper 37468493 Paper 37256909 Paper 36867975 Paper 35976425 Paper 35926776 Paper 35912993 Paper 35133089 Paper 34915736 Paper 34825513 Paper 34321982 Paper 34091721 Paper 34042292 Paper 33765680 Paper 33403824 Paper 33026465 Paper 32900691 Paper 32561654 Paper 32405588 Paper 32149733 Paper 32066273 Paper 31880949 Paper 31863294 Paper 31790303 Paper 31760802 Paper 31017011 Paper 30793930 Paper 30610358 Paper 30066583 Paper 29392338 Paper 29357436 Paper 29279874 Paper 29126251 Paper 28980082 Paper 28822796 Paper 28784428 Paper 28154201 Paper 27913855 Paper 27824271 Paper 27612997 Paper 27549355 Paper 27452364 Paper 27038771 Paper 26956131 Paper 26924944 Paper 26608788 Paper 26555954 Paper 26526044 Paper 26414908 Paper 26376133 Paper 25988516 Paper 25947170 Paper 25656372 Paper 25615853 Paper 25108546 Paper 25096802 Paper 25014576 Paper 24657667 Paper 24478243 Paper 24089413 Paper 23917165 Paper 23881525 Paper 23863465 Paper 23720347 Paper 23438422 Paper 23228113 Paper 23177635 Paper 23159588 Paper 23159272 Paper 22976521 Paper 22698623 Paper 22612388 Paper 22591962 Paper 22358148 Paper 22337820 Paper 22245295 Paper 21952643 Paper 21825103 Paper 21123489 Paper 21063698 Paper 21057942 Paper 20818905 Paper 20818325 Paper 20719342 Paper 20652560 Paper 20632168 Paper 20625890 Paper 20623223 Paper 20428098 Paper 20411383 Paper 20132593 Paper 20035974 Paper 19814580 Paper 19710630 Paper 19640901

Abstract

The overall objective of the proposed research is to understand the molecular basis for the hypercalciuria of human idiopathic hypercalciuria (IH). Features of IH including normal serum CA, increased intestinal Ca absorption, and negative Ca balance and bone loss exaggerated by low Ca diet are also found in the genetic hypercalciuric stone-forming (GHS) rat, which is a unique animal model to study human hypercalciuria and nephrolithiasis. Like some patients with IH, GHS rats have normal serum 1,25 (OH)2D3 levels. Elevated vitamin D receptor (VDR) levels in intestine, kidney, bone, and splenic monocytes may mediate the hypercalciuria in GHS rats by exaggerating 1,25 (OH)2D3 biologic actions. Peripheral blood monocytes (PBMs) from IH patients overproduce cytokines (IL-1alpha and beta, IL-6), TNFalpha, and GM- CSF) that have osteoclast-stimulating activity. Pathologic increases in VDR and/or over-production of cytokines may result in the IH phenotype and both hypotheses will be tested in IH patients and GHS rats. The hypotheses will be tested in three specific aims: 1. That IH patients with normal serum 1,25 (OH)2D3 have excessive VDR and exaggerated vitamin D target tissue response to 1,25(OH)2D3 and that PBMs overproduce cytokines. Studies in IH patients will measure: a) dermal fibroblast and PBM VDR levels, 24-hydroxylase(24- OHase) activity, and PBM cytokine production; b) duodenal VDR levels and Ca absorption; and c) 1,25 (OH)2D3-dependent and independent bone resorption. 2. That VDR is constitutively increased in GHS rats by measuring VDR under conditions that modulate VDR levels in normal rats: a) decreased VDR as during aging, high Ca diet, parathyroid hormone; b) increased VDR as during low Ca diet, and low phosphate diet; and c) nephron co- localization of VDR, calbindin 28 kd, and Ca-sensing receptor. 3. Cytokine production in GHS rats: a) in vitro LPS- and 1,25 (OH)2D3- stimulated; b) during low Ca diet; c) effect of in vivo inhibition of IL- 1beta, TNFalpha action on urine Ca, intestinal Ca transport, and VDR levels; and d) effect of in vitro cytokines on monocyte VDR, and 24 - OHase activity. The proposed studies should lead to novel approaches to the treatment and prevention of hypercalciuria and Ca nephrolithiasis.

View original record on NIH RePORTER →